Sign in to fuzzto save your conversations, follow your research and come back anytime.
Ganga Pharmaceuticals
SectorHealthcare
| Metric (₹ crore) | Q1 FY25 | Q2 FY25 |
|---|---|---|
| Sales | 0 | 1.31 |
| Expenses | 0 | 1.42 |
| EBITDA | 0 | -0.11 |
| Depreciation | 0 | 0.02 |
| EBIT | 0 | -0.13 |
| Interest | 0 | 0.09 |
| Profit Before Tax | 0 | -0.22 |
| Net Profit | 0 | 0.02 |
| EPS | 0 | 0.05 |
| Metric (₹ crore) | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 0.27 | -1.05 | 0.05 | 0.24 | 0.11 | -0.31 | -0.18 | -0.21 | -0.04 | -1.26 | -0.58 | -1.31 |
| Investing Cash Flow | -0.18 | -0.83 | 0.62 | -0.14 | 0.28 | 0.37 | 0.28 | 0.19 | 0.49 | 0.13 | 1.18 | 0.24 |
| Financing Cash Flow | -0.06 | 1.9 | -0.33 | -0.36 | -0.45 | -0.29 | -0.1 | 0.03 | -0.44 | 1.14 | -0.33 | 0.82 |
| Net Cash Flow | 0.03 | 0.02 | 0.34 | -0.26 | -0.06 | -0.23 | -0 | 0.01 | 0.01 | 0.01 | 0.27 | -0.25 |
| Metric (₹ crore) | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 2.64 | 4.8 | 4.88 | 4.97 | 5.15 | 5.35 | 5.37 | 5.41 | 5.45 | 7.05 | 7.13 | 8.31 |
| Total Liabilities | 2.75 | 2.53 | 2.74 | 3.26 | 2.6 | 2.21 | 2.29 | 2.58 | 2.53 | 1.6 | 1.84 | 1.34 |
| Total Assets | 5.39 | 7.33 | 7.61 | 8.23 | 7.76 | 7.57 | 7.66 | 8 | 7.98 | 8.65 | 8.97 | 9.65 |